Kavalactone Separation by Two-Step Supercritical CO2 Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing kavalactone do not effectively separate kavalactone from flavokawain A and flavokawain B, leading to potential health hazards due to the presence of high amounts of flavokawains in the final product.
Innovation Solution
A method involving two-step supercritical carbon dioxide extraction, re-extraction, adsorption, and crystallization is employed to separate kavalactone from flavokawain A and flavokawain B, utilizing specific temperature and pressure conditions and solvent combinations to achieve high purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional extraction methods (supercritical CO2 or solvent extraction) are used to prepare kavalactone, then kavalactone can be obtained, but flavokawain A and flavokawain B are not effectively separated, leading to high flavokawain content in the final product which poses health hazards
Solution Approach 1:
The extraction process is divided into two distinct stages: first extraction (45-50°C, 15-25 MPa) that selectively extracts flavokawain into the supercritical CO2 phase, and second extraction (30-40°C, 10-15 MPa) that extracts kavalactone. This temporal and parameter-based segmentation allows selective separation of the two compounds based on their different solubility characteristics at different conditions.
Solution Approach 2:
The invention utilizes changes in temperature and pressure parameters to control the solubility and extraction efficiency of different compounds. By adjusting extraction temperature from 45-50°C to 30-40°C and pressure from 15-25 MPa to 10-15 MPa between stages, the selective extraction of flavokawain followed by kavalactone is achieved, effectively separating the two compounds.
2Productivity
If a single-stage supercritical extraction is used, then the process is simple and fast, but the separation of kavalactone and flavokawain is insufficient
Solution Approach 1:
The extraction process is divided into two distinct stages: first extraction (45-50°C, 15-25 MPa) that selectively extracts flavokawain into the supercritical CO2 phase, and second extraction (30-40°C, 10-15 MPa) that extracts kavalactone. This temporal and parameter-based segmentation allows selective separation of the two compounds based on their different solubility characteristics at different conditions.
Solution Approach 2:
The extraction process employs periodic action by conducting sequential extractions at different time periods with different parameters. The first extraction phase removes flavokawain, followed by a second phase that extracts kavalactone. This periodic approach with distinct phases achieves both efficiency and purity.
3Device complexity
If conventional extraction methods are used without separation steps, then the process is simple, but the flavokawain content in the final product remains high causing liver toxicity
Solution Approach 1:
The harmful flavokawain component is selectively extracted and separated from the kavalactone through the two-stage supercritical CO2 extraction process. The first extraction stage specifically targets and removes flavokawain A and B into the supercritical phase, leaving kavalactone in the residue, thereby taking out the harmful substance while preserving the beneficial compound.
Solution Approach 2:
The invention converts the challenge of flavokawain presence into a benefit by using its different extraction characteristics to enable selective separation. By exploiting the fact that flavokawain extracts more readily at higher temperature and pressure, the process selectively removes the harmful component first, then extracts the beneficial kavalactone, turning a potential hazard into a separation advantage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a high separation efficiency of kavalactone, with flavokawain content reduced to 0.05-0.18 wt%, improving safety and shelf life through microencapsulation, and enhancing bioavailability.
Implementation Method 1
extracting by supercritical carbon dioxide and collecting a residue for later use, in which extraction temperature is 45-50 °C and an extraction pressure is 4-8 Mpa
Implementation Method 2
performing re-extraction and adsorption on the extracted oil to obtain a primary product of the kavalactone
Implementation Method 3
crystallizing the primary product of kavalactone to obtain the kavalactone
Data Source
Figure 1~2
AI summary
The present application relates to a technical field of separating kavalactone and flavokawain, and in particular, to a method for separating flavokawain and kavalactone, kavalactone, and microencapsulated kavalactone. The separation method includes: S1. grinding root of piper methysticum, extracting by supercritical carbon dioxide and collecting a residue for later use, in which an extraction temperature is 45-50 °C and an extraction pressure is 4-8 Mpa; S2. extracting the residue by supercritical carbon dioxide, and collecting extracted oil for later use, in which an extraction temperature is 60-80 °C and an extraction pressure is 20-50 Mpa; S3. performing re-extraction and adsorption on the extracted oil to obtain a primary product of the kavalactone; and S4. crystallizing the primary product of kavalactone to obtain the kavalactone. The obtained kavalactone is used for microencapsulated kavalactone.